THERAPEUTIC MONITORING OF PSYCHOTHERAPEUTIC DRUGS - ROLE OF THE CLINICAL LABORATORY

被引：8

作者：

JATLOW, P ^{[1
]}

机构：

[1] YALE UNIV,SCH MED,DEPT PSYCHIAT,NEW HAVEN,CT 06510

来源：

关键词：

D O I：

10.1016/S0009-9120(85)80098-9

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：143 / 148

页数：6

共 53 条

[31] CLINICAL IMPLICATIONS OF 2-HYDROXYDESIPRAMINE PLASMA-CONCENTRATIONS
NELSON, JC
BOCK, JL
JATLOW, PI
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (02) : 183 - 189
[32] NELSON JC, 1980, AM J PSYCHIAT, V137, P1232
[33] NELSON JC, 1982, ARCH GEN PSYCHIAT, V39, P1055
[34] NELSON JC, 1982, ARCH GEN PSYCHIAT, V39, P1419
[35] NELSON JC, 1984, ARCH GEN PSYCHIATRY, V14, P55
[36] PIAFSKY KM, 1977, CLIN PHARMACOL THER, V22, P545
[37] BINDING OF IMIPRAMINE TO PLASMA-PROTEIN AND TO BRAIN-TISSUE - RELATIONSHIP TO CSF TRICYCLIC LEVELS IN MAN
POTTER, WZ
MUSCETTOLA, G
GOODWIN, FK
[J]. PSYCHOPHARMACOLOGY, 1979, 63 (02) : 187 - 192
[38] POTTER WZ, 1980, ARCH GEN PSYCHIAT, V37, P314
[39] ACTIVE METABOLITES OF IMIPRAMINE AND DESIPRAMINE IN MAN
POTTER, WZ
CALIL, HM
SUTFIN, TA
ZAVADIL, AP
JUSKO, WJ
RAPOPORT, J
GOODWIN, FK
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (03) : 393 - 401
[40] POTTER WZ, 1979, BIOL PSYCHIAT, V14, P601